James Kihara, Principal Accounting Officer: Acadia Pharmaceuticals ACAD Sell · Filed 23/11/21

Trade details

Type: Insider sale
Amount: $44,940.4
Shares · price: 1,985 sh · $22.64 a share
Held after: 13,025 sh
Stock: Acadia Pharmaceuticals ACAD
Person: James KiharaPrincipal Accounting Officer
Trade date: 23/11/20
Filed: 23/11/21
Days to filing: 1 days

Sold 13.2% of holdings

Share of holding sold: 13.2%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/10/21~23/12/20

James Kihara's recent trades

James KiharaPrincipal Accounting Officer
Sell10b5-1 planAcadia Pharmaceuticals
Sell10b5-1 plan
Acadia Pharmaceuticals
ACAD
$297.9K
11,421 sh
$297.9K
Filed 06/29
Traded 06/26
James KiharaPrincipal Accounting Officer
Planned sale10b5-1 planAcadia Pharmaceuticals
Planned sale10b5-1 plan
Acadia Pharmaceuticals
ACAD
$297K
11,421 sh
$297K
Filed 06/26
Traded 06/26
James KiharaPrincipal Accounting Officer
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$114.4K
5,401 sh
$114.4K
Filed 05/27
Traded 05/26
James KiharaPrincipal Accounting Officer
Planned saleAcadia Pharmaceuticals
Planned sale
Acadia Pharmaceuticals
ACAD
$114.4K
5,401 sh
$114.4K
Filed 05/26
Traded 05/26
James KiharaPrincipal Accounting Officer
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$29K
1,332 sh
$29K
Filed 05/05
Traded 05/04